Correlation Between H M and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both H M and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining H M and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between H M Hennes and AstraZeneca PLC, you can compare the effects of market volatilities on H M and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in H M with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of H M and AstraZeneca PLC.
Diversification Opportunities for H M and AstraZeneca PLC
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between HM-B and AstraZeneca is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding H M Hennes and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and H M is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on H M Hennes are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of H M i.e., H M and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between H M and AstraZeneca PLC
Assuming the 90 days trading horizon H M Hennes is expected to generate 0.56 times more return on investment than AstraZeneca PLC. However, H M Hennes is 1.8 times less risky than AstraZeneca PLC. It trades about -0.31 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.19 per unit of risk. If you would invest 16,656 in H M Hennes on August 29, 2024 and sell it today you would lose (1,391) from holding H M Hennes or give up 8.35% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
H M Hennes vs. AstraZeneca PLC
Performance |
Timeline |
H M Hennes |
AstraZeneca PLC |
H M and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with H M and AstraZeneca PLC
The main advantage of trading using opposite H M and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if H M position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.H M vs. Telefonaktiebolaget LM Ericsson | H M vs. Swedbank AB | H M vs. AB Electrolux | H M vs. Investor AB ser |
AstraZeneca PLC vs. AB Volvo | AstraZeneca PLC vs. Telefonaktiebolaget LM Ericsson | AstraZeneca PLC vs. H M Hennes | AstraZeneca PLC vs. Investor AB ser |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stocks Directory Find actively traded stocks across global markets |